Answers are grounded in this paper and cite their sources.
Our results demonstrate that KLRC1 knockout is an effective strategy to improve NK cell antitumor activity against HLA-E⁺ tumors and could be applied in the development of NK cell therapy for solid tumors.
No takes yet. Share an insight, caveat, or question.
Donald et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: